Dishman Carbogen Amcis Limited (NSE:DCAL)
India · Delayed Price · Currency is INR 248.85
-19.00 (-7.09%)
Nov 7, 2025, 3:30 PM IST
Dishman Carbogen Amcis Market Cap
Dishman Carbogen Amcis has a market cap or net worth of 39.02 billion as of November 7, 2025. Its market cap has increased by 25.41% in one year.
Market Cap
39.02B
Enterprise Value
58.29B
Revenue
27.84B
Ranking
n/a
PE Ratio
28.61
Stock Price
248.85
Market Cap Chart
Since September 21, 2017, Dishman Carbogen Amcis's market cap has decreased from 56.82B to 39.02B, a decrease of -31.33%. That is a compound annual growth rate of -4.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 39.02B | -8.00% |
| Dec 31, 2024 | 42.41B | 58.22% |
| Dec 29, 2023 | 26.80B | 80.14% |
| Dec 30, 2022 | 14.88B | -52.91% |
| Dec 31, 2021 | 31.60B | 45.21% |
| Dec 31, 2020 | 21.76B | 59.76% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 21, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.05T |
| Divi's Laboratories | 1.83T |
| Cipla | 1.21T |
| Apollo Hospitals Enterprise | 1.12T |
| Mankind Pharma | 953.10B |
| Zydus Lifesciences | 942.54B |
| Fortis Healthcare | 762.43B |
| Alkem Laboratories | 674.77B |